This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Canopy Growth Corporation (CGC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed the most recent trading day at $41.01, moving -1.42% from the previous trading session.
Marijuana ETF Enters Bear Territory: What Lies Ahead?
by Sweta Killa
Despite entering into bear territory, the cannabis ETF is up more than 24% over the past three months and the outlook remains bright.
Marijuana Stocks Plummet to Record Low: What's Next?
by Zacks Equity Research
Legalization has long been considered a boon for the marijuana industry.
The Zacks Analyst Blog Highlights: Tilray, Coca-Cola, Constellation Brands, Canopy Growth and ETFMG
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tilray, Coca-Cola, Constellation Brands, Canopy Growth and ETFMG
Canada Legalizes Marijuana: Stocks & ETF in Focus
by Neena Mishra
Canada legalized recreational pot today but it's "sell the news" event for pot stocks that have seen astronomical gains recently.
The Zacks Analyst Blog Highlights: Altria, Coca-Cola, PepsiCo, Constellation and Canopy Growth
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Altria, Coca-Cola, PepsiCo, Constellation and Canopy Growth
Cannabis Market Attracts U.S. Cigarette Makers As Well
by Zacks Equity Research
With a declining number of cigarette smokers in the United States, cigarette-makers are looking into opportunities in the fast-growing cannabis industry.
Company News For Oct 16, 2018
by Zacks Equity Research
Companies In The News are: JBHT,HRS,SCHW,CGC
Canopy Growth Corporation (CGC) Stock Moves -1.77%: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed the most recent trading day at $47.86, moving -1.77% from the previous trading session.
Tilary Buys Alef Biotechnology to Build Base in Latin America
by Zacks Equity Research
Tilary (TLRY) acquires import and distribution partner, Alef Biotechnology to strengthen its base in Latin America.
Walmart's Canada Unit Eyes Prospects in Cannabis Products
by Zacks Equity Research
Walmart (WMT) explores opportunities to sell cannabis-infused products in Canada.
Bear of the Day: Constellation Brands (STZ)
by Benjamin Rains
This alcoholic beverage giant is embarking on a new journey and its earnings revisions are trending in the wrong direction.
Molson Coors and HEXO Joint Venture Goes Live as "Truss"
by Zacks Equity Research
Molson Coors Canada (TAP) and Hydropothecary launch its JV, Truss, to explore the non-alcoholic cannabis-infused drinks market, just before cannabis trade is legalized in Canada.
Constellation Brands (STZ) Down Ahead of Earnings: What To Expect
by Ryan McQueeney
Shares of Constellation Brands fell 1% during regular market hours Wednesday, the last trading period before the alcohol giant posts its latest quarterly earnings report. Here's what to expect when the company reports tomorrow.
Do Options Traders Know Something About Canopy Growth (CGC) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Canopy Growth (CGC) stock based on the movements in the options market lately.
Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $48.87, marking a +0.43% move from the previous day.
Pot Stocks & ETF: Risks and Rewards
by Neena Mishra
Here is what investors need to know about risks and rewards of investing in the emerging marijuana industry.
Top Wall Street Stories of the Third Quarter
by Sweta Killa
We discuss some of the events that dominated the headlines in the third quarter and influenced the market.
Has the Earnings Picture Started Weakening?
by Sheraz Mian
A big part of the positive revisions over the last two quarters was due to the direct impact of the tax cuts. With that issue now behind us, the revisions trend appears to be moving back to how it has behaved over the last few years.
Canopy Growth Corporation (CGC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $52.70, marking a +0.46% move from the previous day.
Wall Street's Reefer Madness, Micron Earnings, & More Stock News
by Ryan McQueeney
Ryan McQueeney and Maddy Johnson discuss the performance of Netflix and other streaming services at the Emmys. The team also chat about the alleged criminal probe facing Elon Musk and Tesla. Later, they discuss marijuana stocks and recap Micron's latest earnings report.
Is Goldilocks Market Coming?
by Zacks Equity Research
Is Goldilocks Market Coming?
How Much Longer for the Goldilocks Market?
by Mark Vickery
Investors who've been around the block a few times tend to look for something around the corner that threatens to stick a pin in this ever-expanding balloon.
Cannabis Company Tilray's (TLRY) Shares Up 856% Since July
by Zacks Equity Research
Tilray (TLRY) inks an import deal with the U.S. Drug Enforcement Administration for a trial on neurological movement disorder.
Know How Beverage Stocks Will Gain From Shift to Marijuana
by Rajani Lohia
Cannabis-infused drinks have emerged as an attractive alternative to the problems of the players in the U.S. beverage space, given the health benefits it offers.